IGF-1 LR3 · 1MG
Long R3 IGF-1: an 83-amino acid analog of insulin-like growth factor 1 with extended half-life, studied for cellular proliferation and differentiation.
These products are sold strictly for in-vitro laboratory research and are not intended for human consumption, diagnosis, treatment, or any therapeutic use. Purchaser must be 18 years of age or older and confirms they are a qualified researcher.
Product Information
Research DatasheetProduct Overview
IGF-1 LR3 is an 83-amino acid analog of insulin-like growth factor 1 featuring an N-terminal extension and an arginine substitution at position 3, which extends its half-life relative to native IGF-1. It is used in laboratory research to investigate IGF-1 receptor signaling, cellular proliferation, protein synthesis, and anabolic pathways. Lyophilized under sterile conditions. For laboratory research use only. Not for human or veterinary use.
Molecular Profile
Research Applications
- ◆Cellular proliferation and differentiation research
- ◆IGF signaling pathway studies
- ◆Anabolic pathway research models
- ◆Protein expression and synthesis research
- ◆mTOR pathway investigations
- ◆Growth factor pharmacology
Quality Standards
For in-vitro research use only. Not for human consumption, diagnosis, or treatment.
Long R3 IGF-1: an 83-amino acid analog of insulin-like growth factor 1 with extended half-life, studied for cellular proliferation and differentiation. All ENOS research vials are lyophilized, sealed under sterile conditions, and shipped with cold-chain packaging where appropriate. A downloadable Certificate of Analysis is available on request for every batch.
You may also like

HGH

HGH · 10IU
Recombinant human growth hormone research vial — 99% purity. Now available.

HGH 191AA

HGH 191AA · 15IU
Recombinant human growth hormone research vial — 15IU, 99% purity.

HGH 191AA

HGH 191AA · 24IU
Highest-yield HGH 191AA research vial — 24IU, 99% purity.

Tesamorelin

Tesamorelin · 10MG
Clinically researched peptide studied for natural growth hormone release.